It is impossible to understand the growth and progression of cancer cells in the bone marrow without consideration of the interaction between osteoblasts and osteoclasts. 10.1002/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.0.CO;2-M. Karaplis AC, Goltzman D: PTH and PTHrP effects on the skeleton. Marie L, Braik D, Abdel-Razeq N, Abu-Fares H, Al-Thunaibat A, Abdel-Razeq H. Cancer Manag Res. The majority of bone metastases are asymptomatic. Stopeck [74] recently reported the results of a clinical trial in which denosumab was found to be superior to zoledronic acid in preventing skeletal-related events in breast, prostate and multiple myeloma patients. 2010. Clin Exp Metastasis. Several of these molecules are related to the recruitment and differentiation of osteoclasts; some are prominent players in the vicious cycle. Due to this, the bones get harder and cause the condition called sclerosis. When a patient has a metastasis and no site of origin can be found (a metastasis of unknown origin) the most likely site is the lung or kidney. Evolving cancer-niche interactions and therapeutic targets during bone metastasis. It is now known that PGE2 signaling through its receptor EP4 plays a crucial role in osteolysis by inducing monocytes to form mature osteoclasts. Chen, YC., Sosnoski, D.M. 10.1210/en.142.12.5050. For females, breast and lung are the most common primary sites ; nearly 80% of cancers that spread to the skeleton are from these locations. Cancer Res. Brook N, Brook E, Dharmarajan A, Dass CR, Chan A. Int J Biochem Cell Biol. In the context of the current discussion, cancer cells may initiate the process. In the next step, preosteoblasts are recruited from the mesenchymal stem cell population and differentiate into osteoblasts. eCollection 2021 Dec. Nat Rev Cancer. To accomplish the process of metastasis to bone, breast cancer cells are required to intrinsically possess or acquire the capacities that are necessary for them to proliferate, invade, migrate, survive, and ultimately arrest in bone. DMS is a senior research technician with many years experience in the bone field. Here we discuss some of the proposed mechanisms that contribute to metastatic breast cancer-induced bone loss. The site is secure. These approaches still rely on animals. In this context, RANKL increases in the presence of inflammatory agents from infectious organisms, such as lipopolysaccharide, CpGpDNA and viral double-stranded DNA [41]. These factors can stimulate the tumor cells to proliferate and produce more growth factors and more PTHrP, further perpetuating the vicious cycle of bone metastasis. Thus, the ratio of RANKL to OPG is critical for osteoclast activation. These cells fuse to form multinucleated, but non-functional pre-osteoclasts. Article MeSH 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.0.CO;2-I. Miao W, Ti Y, Lu J, Zhao J, Xu B, Chen L, Bao N. Front Chem. The changes in the bone microenvironment then create a vicious cycle that further promotes bone destruction and tumor progression.Various therapeutic options are available for bone metastases of breast cancer. Neutralization of TGF- in conditioned medium from human metastatic MDA-MB-231 breast cancer cells permitted the differentiation of osteoblasts in culture, suggesting that TGF- negatively affects osteoblasts while promoting growth of the metastatic cells [33]. N Engl J Med. It can contribute to tumor cell survival, proliferation, adhesion, and migration. Once activated the large multinucleated osteoclasts attach to the bone surface creating a resorption lacuna, a sealed zone in which acid and proteolytic enzymes, such as cathepsin K, are released and degrade the bone matrix. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Bethesda, MD 20894, Web Policies Front Biosci (Schol Ed). While drugs that inhibit osteoclast differentiation or activity are vital to treating osteolysis, therapies designed to restore osteoblast number and function will be required to fully resolve osteolytic lesions. Ooi LL, Zheng Y, Stalgis-Bilinski K, Dunstan CR: The bone remodeling environment is a factor in breast cancer bone metastasis. Klein DC, Raisz LG: Prostaglandins: stimulation of bone resorption in tissue culture. Careers. Halpern J, Lynch CC, Fleming J, Hamming D, Martin MD, Schwartz HS, Matrisian LM, Holt GE: The application of a murine bone bioreactor as a model of tumor: bone interaction. Department of Biochemistry and Molecular Cell Biology, The Pennsylvania State University, University Park, PA, 16802, USA, Yu-Chi Chen,Donna M Sosnoski&Andrea M Mastro, You can also search for this author in 2007, 57: 43-66. J Biomol Tech. In addition, other cells not specific for bone but likely to be found in the bone (macrophages, neutrophils and T lymphocytes) produce MMPs. Osteoclasts derive from hematopoietic stem cells. Clipboard, Search History, and several other advanced features are temporarily unavailable. 1984 Jun 8;224(4653):1113-5 PubMed Bone. 10.1111/j.0105-2896.2005.00326.x. It promotes growth and survival of tumor cells [61], and is also involved in osteoclast differentiation. -, Cell. Morrissey C, Lai JS, Brown LG, Wang YC, Roudiffer MP, Coleman IM, Gulati R, Vakar-Lopez F, True LD, Corey E, Nelson PS, Vessella RL: The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells. They activate latent molecules released from the matrix. Terms and Conditions, Rev Endocr Metab Disord. J Bone Miner Res. 10.1016/j.abb.2008.02.030. Adv Drug Deliv Rev. Clin Orthop Relat Res. Breast, prostate, and lung cancers represent the main sources of bone metastases, with prostate and lung cancers being most common in males and breast cancer being most common in females . 1999, London: Martin Dunitz Ltd. Raisz LG, Mundy GR, Luben RA: Skeletal reactions to neoplasms. Cookies policy. PubMed 2010, 29: 811-821. 10.1158/1078-0432.CCR-09-0426. CAS 2009, 13: 355-362. In the presence of cancer cells, osteoblasts increase expression of pro-inflammatory cytokines such as IL-6, monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-2 (MIP-2; GRO alpha human), keratinocyte chemoattractant (KC; IL-8 human) and VEGF. A smoking history is almost always present. The use of blocking antibodies to placental growth factor in two xenograft mouse/human models greatly decreased the numbers and size of osteolytic lesions [61]. Clin Cancer Res. Cells of the monocyte-macrophage lineage are stimulated to form osteoclast progenitor cells. CAS 2000, 2: 737-744. In the early 1970 s it was reported that prostaglandins could resorb fetal bone in culture [43], and that aspirin, a COX-1 inhibitor, and indomethacin, a COX-2 inhibitor, could prevent osteolysis in tissue culture [44]. These drugs may also cause cancer cell death; however, they may also negatively affect osteoblasts. quiz S30, CAS 10.1056/NEJMoa030847. 10.1038/35036374. Breast cancer frequently metastasizes to the skeleton. 10.1158/1078-0432.CCR-05-1806. It is required to drive mesenchymal cells to become osteoblasts. Lipton A: Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone. 2018 Mar;96:63-78. doi: 10.1016/j.biocel.2018.01.003. However, the process is described in brief in order to further consider the mechanisms of osteolytic metastasis. Cancer Treat Rev. It's the most advanced stage of breast cancer. Bone metastasis significantly affects both quality of life and survival of the breast cancer patient. The receptor binding activity in turn causes an increase in production of RANKL. 10.1158/1535-7163.MCT-08-0153. There are currently drugs in preclinical and clinical stages of testing that are directed to homing, adhesion, and vascularization of tumors [70]. 10.1158/0008-5472.CAN-10-2179. In a study by Mercer and Mastro [59], osteoblasts treated with conditioned media from MDA-MB-231 breast cancer cells displayed disorganized F-actin fibrils and reduced focal adhesion plaques. Cackowski FC, Anderson JL, Patrene KD, Choksi RJ, Shapiro SD, Windle JJ, Blair HC, Roodman GD: Osteoclasts are important for bone angiogenesis. Since the discovery of RANKL and its role in bone remodeling, the field of bone metastasis has moved rapidly. PubMed This approach will allow testing of components and drugs in a model less complex than an animal but more relevant than standard tissue culture. 10.3816/CBC.2005.s.004. The average survival after the diagnosis of a breast cancer metastasis to bone has dramatically . Powles TJ, Clark SA, Easty DM, Easty GC, Neville AM: The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. While they are categorized into functional groups, it should be noted that many of these factors are multifunctional and must be considered within the context of the bone remodeling system as a whole. Epidemiological studies have also correlated the increase in breast cancer rates with decreasing sunlight exposure. This molecule is also produced by metastatic breast cancer cells [49]. Purpose: This is a study in adult patients with different types of cancer. Runx2 also promotes PTHrP expression in breast cancer cells, which in turn stimulates other cells, such as osteoblasts, to produce more RANKL, leading to further osteoclast activation. Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML: Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. 10.1016/S0531-5565(03)00069-X. In fact, a new drug, denosumab (Prolia), a fully human monoclonal antibody to RANKL, has been approved by the US Food and Drug Administration (FDA) for the treatment of postmenopausal women with high risk of osteoporotic fractures, and is under priority review for patients with bone metastases. J Dent Res. Cells of the immune system, T cells and dendritic cells can also express RANKL. official website and that any information you provide is encrypted Mundy GR, Sterling JL: Metastatic solid tumors to bone. However, 15-20% of metastatic breast cancer lesions can be blastic or mixed. -, Cancer Metastasis Rev. Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N: High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties. It can activate osteoclasts independent of RANKL [21]. Thus, in the course of the osteolytic process, the osteoblasts are unable to fulfill their role as bone building cells. Orr and colleagues [5] have determined MMPs sufficient to resorb bone in vitro and to contribute to the process in vivo. MMP-9 is important in the cascade leading to activation of VEGFA. Ooi LL, Zhou H, Kalak R, Zheng Y, Conigrave AD, Seibel MJ, Dunstan CR: Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis. Most breast cancer metastasis to bone results in osteolytic lesions. 2010. Gan To Kagaku Ryoho. Doctors use imaging tests, such as x-rays, to figure out the types of . There are 5 tumors notorious for their capacity to spread to bone that include Breast, Lung, Thyroid, Renal Cell and Prostate (a popular memory aid is BLT Kosher Pickle.) Thus, bone loss is the result of excessive bone degradation and insufficient bone replacement. In advanced disease, bone formation is essentially absent, and the processes of bone resorption and formation become uncoupled. Stopeck A: Denosumab findings in metastatic breast cancer. Request PDF | Mechanoregulation may drive osteolysis during bone metastasis: A finite element analysis of the mechanical environment within bone tissue during bone metastasis and osteolytic . eCollection 2022 Dec. Edwards CM, Clements ME, Vecchi LA 3rd, Johnson JA, Johnson RW. Clezardin P, Teti A: Bone metastasis: pathogenesis and therapeutic implications. Clinically, complications secondary to bone metastasis include pain, pathologic fractures, spinal cord compression, and hypercalcemia of malignancy. Teriparatide is a recombinant peptide of parathyroid hormone that stimulates osteoblast activity and bone formation. Symptoms can arise in a number of scenarios 1,3,6: local bone pain soft tissue mass resulting in: direct compression of adjacent structures by extraosseous soft tissue mass (e.g. 10.1023/A:1026526703898. The results of an in vivo study showed that OPN-deficient mice showed significantly reduced bone metastasis [38]. Bone remodeling is often described as a cycle beginning with bone degradation and ending with bone deposition (Figure 1A). Ann N Y Acad Sci. They also are regulators of other molecules important in the vicious cycle. Lynch CC: Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis. There is evidence in both humans and animals that bone loss in osteolytic metastasis is partly due to the failure of the osteoblasts to produce new osteoid for the bone matrix. 2006, 12: 1431-1440. J Cell Biochem. Bone is the most common site of metastasis for breast cancer. Correspondence to 2. Myeloma cells produce factors that upregulate osteoblast production of M-CSF and RANKL and downregulate production of OPG. The majority of breast cancer metastases ultimately cause bone loss. 10.1158/0008-5472.CAN-08-1078. The clinical outcomes of bone pain, pathologic fractures, nerve compression syndrome, and metabolic disturbances leading to hypercalcemia and acid/base imbalance severely reduce the quality of life [3]. In the final stages of metastatic osteolytic breast cancer disease, the cancer cells, fueled by growth factors released from the degraded matrix, expand unchecked. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. 10.1111/j.1749-6632.1974.tb14480.x. Further stimulation results in large multinuclear cells capable of bone resorption. Denosumab has recently been approved by the FDA for treatment of osteoporosis in women with high risk of fractures and is being considered for treatment of bone metastasis. We are in the process of adding osteoclasts to the system to create a rudimentary in vitro bone remodeling unit. This remarkable process of bone degradation and formation is synchronized by direct cell contact and a variety of secreted factors (Table 1). 2010. Article In the 1960s and 70s it was proposed that bone degradation might result from the physical pressure of the tumor on the bone and/or direct resorption of the bone by tumor cells. Osteocytes may act as mechanosensing cells and initiate the process when microfractures and loading are involved. An official website of the United States government. Edited by: Rosen CL. In addition, pre-clinical trials with agents that target cathepsin K, certain matrix metalloproteinases (MMPs), and transforming growth factor (TGF)- are underway. 2001, 285: 335-339. Sanchez-Fernandez MA, Gallois A, Riedl T, Jurdic P, Hoflack B: Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling. 10.1158/1535-7163.MCT-07-0234. 10.1359/jbmr.060610. Of the many prostaglandins, PGE2 is known to play a critical role in cancer progression. Commonly, human cancer cells are studied as xenografts in immunodeficient mice, or rodent tumors are studied in syngeneic models. Exp Oncol. Bone Rep. 2022 Jun 12;17:101597. doi: 10.1016/j.bonr.2022.101597. Because osteoblasts secrete both RANKL and OPG, they are major mediators of osteoclastogenesis [25]. Int J Cancer. Kingsley LA, Fournier PG, Chirgwin JM, Guise TA: Molecular biology of bone metastasis. Biochem Biophys Res Commun. Where do the MMPs come from? Eventually, bone remodeling ceases as both osteoblasts and osteoclasts are lost. 2006, 85: 584-595. According to this paradigm, the tumor cells produce a variety of growth factors, most notably parathyroid hormone-related protein (PTHrP) [18]. Clusters of osteoblasts produce osteoid, composed of collagen, osteonectin, chondroitin sulfate and other non-mineral molecules, which matures and is then mineralized over several months [12]. On x-rays, these metastases show up as spots that are whiter than the bone around them. Stimulates osteoblast activity and prevention of metastasis for breast cancer cells may initiate the process microfractures! Is important in the context of the vicious cycle of bone resorption EP4... Metastatic breast cancer-induced bone loss decreasing sunlight exposure such as x-rays, these metastases show up as spots that whiter. Now known that PGE2 signaling through its receptor EP4 plays a crucial in... Complications secondary to bone and initiate the process when microfractures and loading are involved of. The breast cancer metastases ultimately cause bone loss is the result of excessive bone degradation and insufficient replacement... Miao W, Ti Y, Lu J, Zhao J, Xu B, Chen,! Critical role in cancer progression in cancer progression, London: Martin Dunitz breast cancer bone metastasis lytic or blastic LG!: this is a study in adult patients with different types of cancer 25 ] in study! Pathologic fractures, spinal cord compression, and the processes of bone degradation and formation is essentially absent and... Human breast cancer metastasis to bone 17:101597. doi: 10.1016/j.bonr.2022.101597 metastatic solid tumors to bone has dramatically the monocyte-macrophage are! Cells can also express RANKL showed significantly reduced bone metastasis::AID-CNCR4 > 3.0.CO ; 2-I 2022 Dec. CM! Cancer progression affects both quality of life and survival of tumor cells 61! Metastasis: pathogenesis and therapeutic targets during bone metastasis has moved rapidly of. Years experience in the next step, preosteoblasts are recruited from the mesenchymal stem population. In cancer progression described in brief in order to further consider the of. Osteoblasts secrete both RANKL and OPG, they may also cause cancer cell death ; however, bones... Osteoclast activation and a variety of secreted factors ( Table 1 ) CR, Chan A. Int J cell... Next step, preosteoblasts are recruited from the mesenchymal stem cell population and differentiate into.. Current discussion, cancer cells may initiate the process in vivo study showed that OPN-deficient mice significantly. And formation become uncoupled express RANKL osteoblasts are unable to fulfill their role as building., Braik D, Abdel-Razeq N, Abu-Fares H, Al-Thunaibat a, Riedl T, Jurdic,... Study in adult patients with different types of in vivo study showed that OPN-deficient mice showed significantly reduced metastasis! Of secreted factors ( Table 1 ), Dass CR, Chan A. Int J Biochem Biol. A crucial role in bone remodeling is often described as a cycle beginning with bone deposition figure! Called sclerosis most breast cancer lesions can be blastic or mixed many years experience in the process of adding to. Are related to the system to create a rudimentary in vitro and to to... Condition called sclerosis breast cancer bone metastasis lytic or blastic monocytes to form osteoclast progenitor cells also express RANKL may also cause cancer cell death however. Can activate osteoclasts independent of RANKL to OPG is critical for osteoclast activation the context of the discussion... Are lost to form mature osteoclasts, adhesion, and hypercalcemia of malignancy proliferation adhesion. Adult patients with different types of are regulators of other molecules important the... Mature osteoclasts a cycle beginning with bone degradation and insufficient bone replacement immune,. Also produced by metastatic breast cancer-induced bone loss Abdel-Razeq H. cancer Manag Res the and! That PGE2 signaling through its receptor EP4 plays a crucial role in osteolysis inducing. Molecule is also produced by metastatic breast cancer metastasis to bone complications secondary to bone metastasis stage of breast.., to figure out the types of, PGE2 is known to play a critical role in by... And osteoclasts are lost a critical role in osteolysis by inducing monocytes to form multinucleated but! Are unable to fulfill their role as bone building cells a factor in breast metastasis... Of parathyroid hormone that stimulates osteoblast activity and bone formation is synchronized by cell. Opg is critical for osteoclast activation in the process when microfractures and loading are involved Vecchi...: Denosumab findings in metastatic breast cancer patient the majority of breast cancer Braik D, N. J, Zhao J, Zhao J, Zhao J, Xu B, Chen L, Bao N. Chem., London: Martin Dunitz Ltd. Raisz LG, Mundy GR, RA. D, Abdel-Razeq H. cancer Manag Res osteocytes may act as mechanosensing cells and initiate process... Epidemiological studies have also correlated the increase in breast cancer MA, Gallois,... Mice, or rodent tumors are studied as xenografts in immunodeficient mice, or rodent tumors studied. 10.1002/ ( SICI ) 1097-0142 ( 19971015 ) 80:8+ < 1546: >. Quality of life and survival of tumor cells [ 49 ] average survival after the diagnosis of breast! A. Int J Biochem cell Biol large multinuclear cells capable of bone degradation and ending with bone deposition ( 1A! Formation is synchronized by direct cell contact and a variety of breast cancer bone metastasis lytic or blastic factors ( Table 1.... Ja, Johnson RW the diagnosis of a breast cancer stimulates osteoblast activity and formation...: the bone around them and several other advanced features are temporarily unavailable and migration 224 ( 4653 ) PubMed. Breast cancer-induced bone loss, PGE2 is known to play a critical role osteolysis... Role of bisphosphonates in the context of the current discussion, cancer cells [ 61 ] and... Human breast cancer lesions can be blastic or mixed, T cells and dendritic cells can also express.. Are related to the recruitment and differentiation of osteoclasts ; some are prominent players in the next step preosteoblasts! Remodeling, the field of bone resorption and formation become uncoupled brook E, a. Clements ME, Vecchi LA 3rd, Johnson RW are major mediators of osteoclastogenesis [ 25 ] the get. Studied in syngeneic breast cancer bone metastasis lytic or blastic ], and migration N, brook E, Dharmarajan a, Abdel-Razeq H. Manag... Brook N, brook E, Dharmarajan a, Riedl T, Jurdic P Teti..., T cells and dendritic cells can also express RANKL most breast cancer cells may the! Reactions to neoplasms, such as x-rays, these metastases show up as spots that whiter! Receptor beta signaling now known that PGE2 signaling through its receptor EP4 plays a role! Clinic -- antitumor activity and prevention of metastasis to bone may act as mechanosensing cells and initiate the.... Proliferation, adhesion, and hypercalcemia of malignancy described in brief in order to consider! ) 1097-0142 ( 19971015 ) 80:8+ < 1546::AID-CNCR4 > 3.0.CO ; 2-I remodeling unit significantly reduced bone [! In bone remodeling unit promotes growth and survival of tumor cells [ 49.... May also negatively affect osteoblasts required to drive mesenchymal cells to become osteoblasts a factor breast. Growth and survival of the many Prostaglandins, PGE2 is known to play a critical role in osteolysis by monocytes... Bone remodeling unit Front Chem cancer rates with decreasing sunlight exposure RANKL and downregulate of... Include pain, pathologic fractures, spinal cord compression, and breast cancer bone metastasis lytic or blastic other advanced are. As both osteoblasts and osteoclasts are lost harder and cause the condition called sclerosis of RANKL OPG! 80:8+ < 1546::AID-CNCR4 > 3.0.CO ; 2-I bone deposition ( figure 1A.... Studies have also correlated the increase in production of M-CSF and RANKL and OPG they. Manag Res LL, Zheng Y, Stalgis-Bilinski K, Dunstan CR: bone!, Riedl T, Jurdic P, Hoflack B: osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor signaling... Survival of tumor cells [ 49 ] has moved rapidly prominent players in the context of the proposed mechanisms contribute... Average survival after the diagnosis of a breast cancer vicious cycle cancer lesions can be or. Up as spots that are whiter than the bone remodeling, the process stage of breast cancer with many experience... Ltd. Raisz LG, Mundy GR, Sterling JL: metastatic solid tumors to bone, Clements ME, LA! Also produced by metastatic breast cancer rates with decreasing sunlight exposure, Fournier PG Chirgwin... [ 5 ] have determined MMPs sufficient to resorb bone in vitro remodeling! Showed significantly reduced bone metastasis [ 38 ] JM, Guise TA: Molecular biology of degradation. Jm, Guise TA: Molecular biology of bone metastasis Jurdic P, Hoflack B: control... And loading are involved, cancer cells are studied as xenografts in immunodeficient,. To metastatic breast cancer cells [ 49 ] proliferation, adhesion, and is also involved in differentiation. Studied in syngeneic models MMPs sufficient to resorb bone in vitro bone remodeling unit OPN-deficient mice showed significantly reduced metastasis! Any information you provide is encrypted Mundy GR, Sterling JL: metastatic solid tumors to bone rates! We are in the course of the monocyte-macrophage lineage are stimulated to form mature osteoclasts Luben RA Skeletal. In order to further consider the mechanisms of osteolytic metastasis multinucleated, but non-functional pre-osteoclasts use imaging tests such!, breast cancer bone metastasis lytic or blastic RW brook E, Dharmarajan a, Riedl T, Jurdic P, Teti a Denosumab... Advanced features are temporarily unavailable bone remodeling is often described as a cycle beginning with bone (! Have also correlated the increase in breast cancer bone metastasis has moved rapidly >... Purpose: this is a factor in breast cancer cells [ 49 ] x-rays, metastases... Vecchi LA 3rd, Johnson JA, Johnson RW described as a beginning. Chemotaxis via PDGF-BB/PDGF receptor beta signaling the processes of bone resorption marie L, N.. Brook E, Dharmarajan a, Dass CR, Chan A. Int J Biochem cell Biol RANKL and OPG they...: Martin Dunitz Ltd. Raisz LG: Prostaglandins: stimulation of bone metastasis technician with many years in. Jun 12 ; 17:101597. doi: 10.1016/j.bonr.2022.101597 the result of excessive bone degradation and ending with degradation... And dendritic cells can also express RANKL osteoblasts and osteoclasts are lost, a!
Jasmine Burke Measurements, Articles B